Login / Signup

Expanding the phenotypic spectrum of CLCN2 -related leucoencephalopathy and ataxia.

Paulo Ribeiro NóbregaAnderson Rodrigues Brandão de PaivaKatiane S SouzaJorge Luiz B de SouzaPedro Lucas Grangeiro de Sá Barreto LimaDelson José da SilvaMilena Sales PitombeiraViviennee K BorgesDaniel A DiasLuciana M BispoCarolina F SantosFernando FreuaPaulo Diego S SilvaIsabela S AlvesLeonardo B PortellaPaulina R CunhaRubens Paulo A SalomaoJosé Luiz PedrosoVeridiana P MiyajimaFábio MiyajimaElisa CaliCharles WadeAnnapurna SudarsanamMary O'DriscollTom HaytonOrlando G P BarsottiniStephan KlebeFernando KokLeandro Tavares LucatoHenry HouldenChristel DepienneDavid S LynchPedro Braga-Neto
Published in: Brain communications (2023)
Mutations in CLCN2 are a rare cause of autosomal recessive leucoencephalopathy with ataxia and specific imaging abnormalities. Very few cases have been reported to date. Here, we describe the clinical and imaging phenotype of 12 additional CLCN2 patients and expand the known phenotypic spectrum of this disorder. Informed consent was obtained for all patients. Patients underwent either whole-exome sequencing or focused/panel-based sequencing to identify variants. Twelve patients with biallelic CLCN2 variants are described. This includes three novel likely pathogenic missense variants. All patients demonstrated typical MRI changes, including hyperintensity on T 2 -weighted images in the posterior limbs of the internal capsules, midbrain cerebral peduncles, middle cerebellar peduncles and cerebral white matter. Clinical features included a variable combination of ataxia, headache, spasticity, seizures and other symptoms with a broad range of age of onset. This report is now the largest case series of patients with CLCN2 -related leucoencephalopathy and reinforces the finding that, although the imaging appearance is uniform, the phenotypic expression of this disorder is highly heterogeneous. Our findings expand the phenotypic spectrum of CLCN2 -related leucoencephalopathy by adding prominent seizures, severe spastic paraplegia and developmental delay.
Keyphrases